When entertaining such thoughts, I paused to consider previous experiences I had on a personal basis.
There appears to be a trendy transition where doctors make money from corporate financings rather than from direct medical research, it is much more lucrative.
But being much more lucrative doesn't necessarily mean the science is bad.
Take another present empolyer of the good doc" Pharmacyte.
Now there's a company for you, with the good doc they say they have promising treatments for of all things, pancreatic cancer with their "cell in a box" technology. There are some people who think the tech is valid. This is at least the 3rd name change for this company. Once "Efoodsystems", then "Nuvilex". now "Pharmacyte" I think the doc came late after Efoodsystems changed its name. These companies had lots of dilution. Whatever name, they always lost money.
Efoodsystems had at least 1 product anyway called "Cinnergen" a liquid supplement for diabetics.
This tech has multiple sources of reliability and a historical track record of various areas of observed efficacy.
I have a fairly large position here and continue to add.
News 
Market Data 
Discover 
